摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[4-methoxy-3-(3-morpholin-4-ylpropoxy)-benzyl]-(1-m-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine | 1175086-43-7

中文名称
——
中文别名
——
英文名称
[4-methoxy-3-(3-morpholin-4-ylpropoxy)-benzyl]-(1-m-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine
英文别名
N-[[4-methoxy-3-(3-morpholin-4-ylpropoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine
[4-methoxy-3-(3-morpholin-4-ylpropoxy)-benzyl]-(1-m-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine化学式
CAS
1175086-43-7
化学式
C27H32N6O3
mdl
——
分子量
488.589
InChiKey
IJTBHPAXFRYDQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    36
  • 可旋转键数:
    10
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    86.6
  • 氢给体数:
    1
  • 氢受体数:
    8

文献信息

  • NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI-CANCER AGENTS
    申请人:Konakanchi Durga Prasad
    公开号:US20100298351A1
    公开(公告)日:2010-11-25
    The invention relates to substituted pyrazolo[3,4-d]pyrimidine derivatives of the Formula-(I), or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted pyrazolo[3,4-d]pyrimidine derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti-proliferative effect in a warm-blooded animal such as man.
    该发明涉及式(I)的取代吡唑并[3,4-d]嘧啶生物或其药学上可接受的盐,其具有抗增殖活性,如抗癌活性,并因此在人体或动物体的治疗方法中有用。该发明还涉及制备取代吡唑并[3,4-d]嘧啶生物的方法,含有该化合物的药物组合物,以及其在制造药物时用于在诸如人类之类的温血动物体内产生抗增殖效果的用途。
  • US8349847B2
    申请人:——
    公开号:US8349847B2
    公开(公告)日:2013-01-08
  • [EN] NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI -CANCER AGENTS<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRAZOLO [3, 4 -D] PYRIMIDINE EN TANT QU'AGENTS ANTICANCÉREUX
    申请人:NATCO PHARMA LTD
    公开号:WO2009098715A2
    公开(公告)日:2009-08-13
    The invention relates to substituted pyrazolo [3,4-d] pyrimidine derivatives of the Formula-(I), or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted pyrazolo [3,4-d] pyrimidine derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti- proliferative effect in a warm-blooded animal such as man.
查看更多